Lataa...
Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer
For many years, preclinical and clinical studies have attempted to harness the power of the immune system and focus it on malignant cells in an attempt to improve clinical outcomes for patients with cancer. The current paper describes the landmark phase III trial that led to the first U.S. Food and...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3474245/ https://ncbi.nlm.nih.gov/pubmed/21174555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.77 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|